Carregant...
The tamoxifen derivative ridaifen-B is a high affinity selective CB(2) receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects
Selective estrogen receptor modulators (SERMs) target estrogen receptors (ERs) to treat breast cancer and osteoporosis. Several SERMs exhibit anti-cancer activity not related to ERs. To discover novel anti-cancer drugs acting via ER-independent mechanisms, derivatives of the SERM tamoxifen, known as...
Guardat en:
| Publicat a: | Toxicol Appl Pharmacol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487498/ https://ncbi.nlm.nih.gov/pubmed/29906493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.taap.2018.06.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|